Wegovy Injection (Semaglutide)

Wegovy contains semaglutide and is a prescription injectable medicine used alongside a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in eligible adults with obesity or overweight accompanied by at least one weight-related health condition. It is administered by subcutaneous injection once weekly according to the prescribed treatment regimen.

Key Features & Specifications

Active ingredient: Semaglutide
Medicine class: GLP-1 receptor agonist
Administration: Subcutaneous injection
Frequency: Once weekly
Strengths: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg
Use: Weight management, including weight loss and weight maintenance
Manufacturer: Novo Nordisk
Prescription: Yes

Price range: €130,00 through €230,00

Dosage	Clear

Compare

Add to wishlist

SAVE 15%

more 2 products

SAVE 50%

6 for the price of 3

* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.